WASHINGTON (AP) -- Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.
After more than a year of review, Food and Drug Administration scientists said the drugs appear to increase the risk of cancer after they are used beyond 2 1/2 years. The agency studied several dozen reports of cancer in children taking the drugs, some of which were fatal. Half of the cases were lymphomas, a cancer that attacks the immune system.
The drugs are known as tumor necrosis factor blockers and work by neutralizing a protein that, when overproduced, causes inflammation and damage to bones, cartilage and other tissue. The drugs are prescribed to children with rheumatoid arthritis, inflammatory bowel disorder and Crohn's disease.
The FDA will bolster the "black box" warning on the five drugs sold in the U.S., including Abbott Laboratories' Humira, Johnson & Johnson's Remicade and Simponi, and Enbrel which is co-marketed by Amgen Inc. and Wyeth.
The action also affects Belgian drugmaker UCB's Cimizia, which launched in May.
Along with updating the drugs' labels, the FDA is requiring companies to add information about cancer risks to the medication guides given to patients. The FDA said it is also working with the manufacturers to further define the scope of the cancer risk.
To fully protect your rights fill out the contact on our website, or call 1-800-510-1325 and you will speak with an experienced, licensed attorney from the The Levensten Law Firm within 24 hours.
Website is sponsored by
CALL US NOW FOR A FREE CASE EVALUATION
Terms and Conditions:
By filling out this free consultation form, you are NOT forming an attorney-client relationship. You can only retain an attorney by entering into a fee agreement. By submitting this form you not entering into a fee agreement. This form is just a request for legal advice. Any information that you will receive in response to the above question is general information and you will NOT be charged for the response to this e-mail question.
No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.
I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Since this matter may require advice regarding my home state, I agree that local counsel may be contacted for referral of this matter.
THIS IS AN ADVERTISEMENT
THE ATTORNEY RESPONSIBLE FOR THIS ADVERTISEMENT IS THE LEVENSTEN LAW FIRM
Principle Office is 1420 Walnut Street, Suite 801 Philadelphia, PA 19102
Please note that you are not considered our client unless you have a signed retainer agreement and your case has been accepted.
Prior results do not guarantee or predict a similar outcome with respect to any future matters.
CASE REVIEW
Please fill out and submit the below form and you will be contacted by a qualified, experienced attorney as soon as possible.
Drugs used to treat arthritis and other inflammatory diseases can increase the risk of cancer in children and adolescents.
